Figure 2. Kaplan-Meier survival analysis of DMFS in breast cancer patients. (IMAGE)
Caption
Figure 2. Kaplan-Meier survival analysis of DMFS in breast cancer patients. (A) Association between SUCLA2 expression and DMFS; (B) Association between USP10 expression and DMFS; (C) Association between SUCLA2×USP10 product and DMFS. Patients were stratified by optimal cutoff determined by the ROC method. p-values were calculated by log-rank test. SUCLA2: succinyl-CoA ligase ADP-forming subunit beta; USP10: ubiquitin-specific peptidase 10; DMFS: distant metastasis-free survival.
Credit
© He X, Shao Y, Sun X, 2026. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Usage Restrictions
Credit must be given to the creator.
License
CC BY